Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Génétique et pathophysiologie de maladies neurodéveloppementales et épileptogènes, |
RCV000201390 | SCV000239962 | benign | Abnormality of neuronal migration | 2014-10-31 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003401044 | SCV004106034 | uncertain significance | DYRK1B-related disorder | 2024-02-21 | no assertion criteria provided | clinical testing | The DYRK1B c.625G>A variant is predicted to result in the amino acid substitution p.Val209Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0035% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |